Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001488:Basilar Artery; D001621:Betahistine / Q000008:administration & dosage / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003071:Cognition / Q000187:drug effects; D003704:Dementia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D010919:Placebos; D011581:Psychological Tests; D011725:Pyridines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014705:Verbal Behavior / Q000187:drug effects; D014711:Vertebral Artery
D010919:Placebos; D011725:Pyridines; D014665:Vasodilator Agents; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine